HNRNPK and neoplasm: The number of infiltrative tumor cells in the different treatment groups was compared, revealing that the HNRNPK (K422R) treatment group exhibited a higher number of infiltrative tumor cells at the tumor edge (Figure 7D-E, Supplementary Figure 11G-H).